Haemonetics Corporation

Haemonetics Corporation Misses on EPS, Stock Down 2.16%

Haemonetics Corporation reported an EPS of $0.55, which was below expectations, resulting in a stock decline of 2.16%. Investors may be concerned about the company's performance given the earnings miss. The lack of additional commentary or guidance from management leaves uncertainty about future prospects.